What revenue is expected from Axon?
Analysts expect Axon’s revenue to grow 27.4% year on year to $641 million.
Finance / Earnings
Axon (NASDAQ:AXON), a self-defense company, is set to release its earnings report this Monday after the bell. Investors are keen to see if the company can maintain its strong performance. This article provides a preview of what to expect fr...
Axon's previous quarter was exceptional, with revenues of $603.6 million, a 31.3% increase year-over-year. The company has consistently surpassed analysts' revenue estimates, suggesting strong operational execution.
However, the expected growth rate for this quarter is slightly lower than the previous year, which could be a point of concern for investors. The performance of other companies in the aerospace and defense sector, such as Byrna and AAR, indicates varied outcomes, emphasizing the importance of Axon's specific results.
Axon's stock is down 7.5% over the last month, with an average analyst price target of $781.27 (compared to the current share price of $742).
Analysts expect Axon’s revenue to grow 27.4% year on year to $641 million.
Axon has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 3% on average.
Do you think Axon will meet analyst expectations? Let us know!
Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.